Zydus Lifesciences Share price target & analyst calls
₹1,189.9-16.10 (-1.33%)
As of 13 Nov 2026
Avg 1-year target
12 of 13 long-term calls BUY₹1,375.3615.6% above today's price
Zydus Lifesciences' average 1-year share price target is ₹1,375.36, the average of 11 advisors' latest targets. Targets range from ₹1,040 to ₹1,580.
Latest: Jefferies India ₹1,430 · 5 Nov 2026
14
13 BUY · 1 SELL, all horizons
11
with an active 1Y target
34%
23 of 67 closed calls hit
81
all horizons, open and closed
Watch ZYDUSLIFE for new buy/sell callsGet alertsSee 53 Pharmaceuticals & Biotechnology sector analyst picks
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
All tips · page 2 of 2
AMbyAjit Mishra, ReligareStop-loss hit
1–2 Weeks* · 12 Aug 2026 · entry ₹1,161.6 · via NDTV Profit (Live)exit ₹1,130
SMbySomil Mehta, SharekhanStop-loss hit
1–2 Weeks* · 29 Jul 2026 · entry ₹1,125.3 · via CNBC Awaaz.exit ₹1,095
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 20 Jul 2026 · entry ₹1,160 · via IDBI Capital Research Calls Telegramexit ₹1,138
ICbyIDBI CapitalStop-loss hit
1–2 Weeks* · 15 Jul 2026 · entry ₹1,158 · via IDBI Capital Research Calls Telegramexit ₹1,136
KJbyKavita Jain, Arihant Capital MarketsStop-loss hit
1–2 Weeks* · 23 Jun 2026 · entry ₹1,117 · via CNBC Awaaz.exit ₹1,100
RPbyRajesh Palviya, Axis SecuritiesStop-loss hit
1–2 Weeks* · 10 Jun 2026 · entry ₹1,115.4 · via CNBC Awaaz.exit ₹1,075
AKbyArun Kumar MantriStop-loss hit
1–2 Weeks* · 10 Jun 2026 · entry ₹1,109.2 · via CNBC Awaaz.exit ₹1,090
ABbyAkshay Bhagwat, JM FinancialStop-loss hit
1–2 Weeks* · 8 Jun 2026 · entry ₹1,087.6 · via ET Nowexit ₹1,060
AKbyAshish Kyal, Waves Strategy AdvisorsStop-loss hit
1–2 Weeks* · 4 Jun 2026 · entry ₹1,085.1 · via ET Nowexit ₹1,060
AMbyAjit Mishra, ReligareExpired
1–2 Weeks · 29 Sept 2026 · entry ₹1,217.6 · via NDTV Profit (Live)exit ₹1,132.5
AJbyAnsh Jogendra BhilwarExpired
1–2 Weeks* · 27 Aug 2026 · entry ₹1,160 · via Zee Business (Live)exit ₹1,127.4
SRbySiddharth Rai MangalaTarget hit
Intraday* · 30 Oct 2026 · entry ₹1,204.8 · via Zee Business (Live)exit ₹1,230
CTbyChandan Taparia, Motilal OswalStop-loss hit
Intraday · 26 Oct 2026 · entry ₹1,140.1 · via CNBC Awaaz.exit ₹1,118
VSbyVikas Sethi, Sethi FinmartStop-loss hit
Intraday · 22 Oct 2026 · entry ₹1,116 · via Zee Business (Live)exit ₹1,105
AJbyAnsh Jogendra BhilwarStop-loss hit
Intraday · 13 Oct 2026 · entry ₹1,136.1 · via Zee Business (Live)exit ₹1,117
CTbyChandan Taparia, Motilal OswalStop-loss hit
Intraday* · 8 Jul 2026 · entry ₹1,174 · via NDTV Profit (Live)exit ₹1,145
SRbySiddharth Rai MangalaExpired
Intraday* · 6 Oct 2026 · entry ₹1,151.5 · via Zee Business (Live)exit ₹1,163.3
* Horizon not stated by the source; assumed from how far the target is from the entry price.
Compare Pharmaceuticals & Biotechnology targets
Most-covered stocks in the sector · average 1-year target
- SUNPHARMASun Pharmaceutical Industries Ltd.₹2,214+17.8% · 26 calls
- DRREDDYDr. Reddy's Laboratories Limited₹1,370-0.8% · 21 calls
- CIPLACipla Ltd.₹1,493+7.3% · 17 calls
- ZYDUSLIFE· this stockZydus Lifesciences Limited₹1,375+15.6% · 13 calls
- GLANDGland Pharma Limited₹3,554+6.6% · 11 calls
- LUPINLupin Limited₹2,671+34.9% · 11 calls
Showing 51–81 of 81

